News Focus
News Focus
icon url

wjlknew

03/27/08 9:34 AM

#9472 RE: DewDiligence #9471

So, GTC will be done with PharmAthene in about six months ... at least for a few years (if Protexia is eventually approved)?
icon url

wjlknew

03/27/08 10:47 AM

#9473 RE: DewDiligence #9471

Dew, I suppose we can hope GTC is the eventual recipient of this $5.8 million for advising PharmAthene in setting up its own goat farm.

>>ANNAPOLIS, Md., March 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP ) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism, announced today that it has been awarded a contract modification providing an additional value of $5.8 million for continued development of Protexia®, the Company's broad spectrum chemical nerve agent prophylaxis.<<

Otherwise, today's GTC PR appears to be nothing but fluff.

icon url

keitern

03/27/08 10:51 AM

#9475 RE: DewDiligence #9471

Do you suppose that the revenue from this extension has already been baked into the expected revenues - from the CC:

"we have already booked and included in our forecast $15 million in respective cash receipts from our currently contracted partners"